Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rema Raman

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
International Review of Neurobiology|June 22, 2020
Statistical methods in handling placebo effectRema Raman
Statistics in Medicine|October 6, 2005
A mixed-effects regression model for three-level ordinal response dataRema Raman, Donald Hedeker
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentReisa A Sperling, Rema Raman
Current Topics in Behavioral Neurosciences|December 12, 2024
Achieving Inclusion in Pharmacological Clinical Trials for Alzheimer's DiseaseDoris Molina-Henry, Rema Raman
Therapeutic Hypothermia and Temperature Management|May 14, 2013
Determinants of Pneumonia Risk During Endovascular HypothermiaPatrick Lyden, Karin Ernstrom, Rema Raman
Stroke|August 27, 2011
Two-hour improvement of patients in the National Institute of Neurological Disorders and Stroke trials and prediction of final outcomeThomas M Hemmen, Karin Ernstrom, Rema Raman
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2002
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's diseaseChristopher G Goetz, Sue Leurgans, Rema Raman, et al.
Neurology|April 25, 2007
Quetiapine for agitation or psychosis in patients with dementia and parkinsonismRoger Kurlan, Jeffrey Cummings, Rema Raman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 23, 2013
Trends in antihypertensive drug prescription patterns among ambulatory stroke patients in the United States, 2000-2009Bruce Ovbiagele, Karin Ernstrom, Daniela Markovic, et al.
JAMA Neurology|August 15, 2022
What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?Joshua D Grill, Reisa A Sperling, Rema Raman
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
International Review of Neurobiology|June 22, 2020
Statistical methods in handling placebo effectRema Raman
Statistics in Medicine|October 6, 2005
A mixed-effects regression model for three-level ordinal response dataRema Raman, Donald Hedeker
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentReisa A Sperling, Rema Raman
Current Topics in Behavioral Neurosciences|December 12, 2024
Achieving Inclusion in Pharmacological Clinical Trials for Alzheimer's DiseaseDoris Molina-Henry, Rema Raman
Therapeutic Hypothermia and Temperature Management|May 14, 2013
Determinants of Pneumonia Risk During Endovascular HypothermiaPatrick Lyden, Karin Ernstrom, Rema Raman
Stroke|August 27, 2011
Two-hour improvement of patients in the National Institute of Neurological Disorders and Stroke trials and prediction of final outcomeThomas M Hemmen, Karin Ernstrom, Rema Raman
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2002
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's diseaseChristopher G Goetz, Sue Leurgans, Rema Raman, et al.
Neurology|April 25, 2007
Quetiapine for agitation or psychosis in patients with dementia and parkinsonismRoger Kurlan, Jeffrey Cummings, Rema Raman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 23, 2013
Trends in antihypertensive drug prescription patterns among ambulatory stroke patients in the United States, 2000-2009Bruce Ovbiagele, Karin Ernstrom, Daniela Markovic, et al.
JAMA Neurology|August 15, 2022
What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?Joshua D Grill, Reisa A Sperling, Rema Raman
Pageof 20